This inventor holds 2 USPTO granted patents. Top assignees: Hylapharm, LLC, University of Kansas. Active years: 2022-2025.
Company Filing History:
2 out of 2 
2 out of 571 
Years Active: 2022-2025
Title: The Innovative Contributions of Ryan Moulder
Introduction
Ryan Moulder is an accomplished inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment and vaccine adjuvants. With a total of 2 patents, Moulder's work exemplifies the intersection of innovation and practical application in medicine.
Latest Patents
Moulder's latest patents include "Imidazoquinoline compounds and prodrugs thereof." This technology focuses on TLR7 and TLR8 agonist compounds, compositions, and methods for treating cancers and enhancing vaccine efficacy. Another notable patent is "Platinum(IV) conjugates and methods of use," which provides platinum(IV) compounds and their pharmaceutically acceptable salts, along with compositions and methods for their application.
Career Highlights
Throughout his career, Ryan Moulder has worked with esteemed organizations such as the University of Kansas and Hylapharm, LLC. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Moulder has collaborated with talented individuals in his field, including Daniel J Aires and Jordan Hunt. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Ryan Moulder's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future innovations in cancer treatment and vaccine development.